Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ehlers-Danlos syndrome and regional anesthesia
NL-OMON22447Active, not recruiting
- Sponsor
- University Medical Center Utrecht
- Start
- Nov 2009
- Modality
- Small Molecules, Drug Delivery Systems
- Countries
- 1
01
Overview
Open-label trial of lidocaine, lidocaine + prilocaine and sodium chloride in Ehlers-Danlos syndrome (EDS) (2 arms), sponsored by University Medical Center Utrecht. Primary endpoint: Primary: analgesia after ulnar nerve block. Started Nov 2009; status: active, not recruiting.
02
Drugs
lidocainelidocaine + prilocainesodium chloride
03
Conditions
Ehlers-Danlos syndrome (EDS)
Beyond the preview
Go deeper on NL-OMON22447.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON22447.